Analysts expect Crocs, Inc. (NASDAQ:CROX) to post $187.35 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Crocs’ earnings. The lowest sales estimate is $187.10 million and the highest is $187.60 million. Crocs posted sales of $187.42 million during the same quarter last year, which would indicate a negative year over year growth rate of 0%. The business is expected to announce its next earnings results on Wednesday, March 7th.

On average, analysts expect that Crocs will report full-year sales of $187.35 million for the current fiscal year. For the next year, analysts expect that the firm will post sales of $1.01 billion per share, with estimates ranging from $999.60 million to $1.02 billion. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side analysts that follow Crocs.

A number of research firms have weighed in on CROX. CL King cut Crocs from a “buy” rating to a “neutral” rating in a research report on Monday, November 20th. ValuEngine raised Crocs from a “sell” rating to a “hold” rating in a research note on Monday, November 13th. Zacks Investment Research raised Crocs from a “sell” rating to a “hold” rating in a research note on Wednesday, November 15th. Pivotal Research started coverage on Crocs in a research note on Thursday, October 5th. They set a “hold” rating and a $9.50 target price for the company. Finally, BidaskClub raised Crocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 18th. Nine investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $8.75.

A number of institutional investors have recently added to or reduced their stakes in the business. UBS Asset Management Americas Inc. increased its position in Crocs by 0.3% during the second quarter. UBS Asset Management Americas Inc. now owns 30,036 shares of the textile maker’s stock worth $232,000 after buying an additional 98 shares in the last quarter. Arizona State Retirement System increased its position in Crocs by 0.5% during the second quarter. Arizona State Retirement System now owns 38,588 shares of the textile maker’s stock worth $298,000 after buying an additional 200 shares in the last quarter. Louisiana State Employees Retirement System increased its position in Crocs by 0.7% during the second quarter. Louisiana State Employees Retirement System now owns 30,200 shares of the textile maker’s stock worth $233,000 after buying an additional 200 shares in the last quarter. US Bancorp DE increased its position in Crocs by 1.2% during the second quarter. US Bancorp DE now owns 33,293 shares of the textile maker’s stock worth $257,000 after buying an additional 401 shares in the last quarter. Finally, Texas Permanent School Fund boosted its holdings in shares of Crocs by 1.4% during the second quarter. Texas Permanent School Fund now owns 54,090 shares of the textile maker’s stock worth $417,000 after purchasing an additional 737 shares during the last quarter. 91.97% of the stock is owned by institutional investors.

Shares of Crocs (NASDAQ:CROX) opened at $10.90 on Friday. Crocs has a 1 year low of $5.93 and a 1 year high of $11.23.

COPYRIGHT VIOLATION WARNING: “$187.35 Million in Sales Expected for Crocs, Inc. (CROX) This Quarter” was originally reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/12/09/187-35-million-in-sales-expected-for-crocs-inc-crox-this-quarter.html.

Crocs Company Profile

Crocs, Inc is engaged in the design, development, manufacturing, marketing, distribution and sale of casual lifestyle footwear and accessories for men, women, and children. The Company’s segments include Americas, Asia Pacific and Europe. Its products include footwear and accessories that utilize its closed-cell resin, called Croslite, as well as casual lifestyle footwear that use a range of materials.

Get a free copy of the Zacks research report on Crocs (CROX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs Inc. and related companies with MarketBeat.com's FREE daily email newsletter.